Cap Stock Picks Poised to Rally in the 2nd Half, According to BofA
BofA analyst Carey Hall said Ulta could rebound in 2H26, keeping a $685 price target despite the stock down 20% YTD on weaker consumer demand. BofA also backed elf Beauty ($85 target) and Wayfair, citing easing supply-chain pressures. It maintained bullish targets for Charles River ($220), Dynatrace, MKS ($2H26 top idea), EastGroup, and Samsara.
How this was made
The 30-second read
Why it matters
Because the piece is primarily analyst commentary (targets and narratives) rather than new company disclosures, it is more useful for relative positioning and sentiment than for a fresh fundamental catalyst.
Market read
Traders may use the note to adjust relative exposure to the named turnaround/growth stories, but it likely won’t drive a major repricing without new prints.
What to watch
Execution risk and timing: turnaround/normalization stories (ULTA/W/EGP) and AI infrastructure demand read-through (DT/MKSI/IOT) can slip if macro conditions or customer capex cycles change.
Background
The article summarizes BofA’s small/mid-cap “cap stock picks” and provides maintained price targets and qualitative theses across multiple companies.
Ticker impact
BofA reiterates a bullish view on Ulta, citing a “turnaround is imminent” thesis and maintaining a $685 price target.
Mild upside bias versus peers if traders treat the note as a catalyst; otherwise limited incremental impact.
The article is an analyst call with targets and qualitative rationale, not a fresh earnings/guidance print or operational disclosure.
BofA keeps a bullish stance on elf Beauty, maintaining an $85 price target and pointing to margin expansion and tariff rebound benefits.
Moderate sentiment support; likely more relevant for relative-value trades than for a major repricing.
No new financial results are provided—only a maintained target and macro/operational narrative.
BofA sees Wayfair as a likely winner as supply-chain pressures ease, while noting margins near the lower end of its long-term EBITDA range.
Potential modest rebound in sentiment if investors buy into the normalization timing; not a hard catalyst.
The article provides qualitative guidance on what BofA expects, but no new Wayfair-specific print or contract.
BofA maintains a bullish view on Charles River Laboratories, keeping a $220 price target despite biotech spending declines.
Limited incremental impact unless traders were underweight on the name; more supportive than directional.
This is target-based commentary without new CRL disclosures.
BofA highlights Dynatrace as an “industry disruptor,” citing improving fundamentals and AI/digital modernization driving observability usage.
Potential positive bias for growth/AI infrastructure trades; likely gradual rather than immediate repricing.
No new product metrics, bookings, or guidance are disclosed—only an analyst narrative.
BofA names MKS Instruments as its top 2H26 SMID cap idea, expecting WFE capacity expansions and tech upgrades to support AI infrastructure demand.
More likely to influence medium-term positioning than to trigger a near-term fundamental repricing.
The article is a forward-looking analyst thesis with no new MKSI order/backlog or guidance datapoint.
BofA stays bullish on EastGroup, citing high demand in the US Sunbelt and ongoing data center buildout support.
Potential modest support for the stock/sector relative to industrial REIT peers if the market buys the tailwind timing.
No new leasing/occupancy or guidance figures are provided—this is primarily an analyst outlook.
BofA frames Samsara as a turnaround/growth story, arguing competitive advantages are widening via data scale and platform breadth.
Could help sentiment and reduce perceived downside, but likely not a major catalyst absent new results.
The article provides qualitative competitive claims and expectations rather than fresh company disclosures.
Market effects
Broadly bullish read-through on consumer discretionary retail turnaround (ULTA/ELF), e-commerce normalization (W), and AI infrastructure/observability/industrial tech demand narratives (DT/MKSI/IOT).
EastGroup’s Sunbelt industrial demand framing may reinforce regional industrial REIT sentiment.
Tariff rebound and supply-chain easing assumptions are macro inputs that can affect multiple discretionary and industrial/tech demand expectations.
Counterpoint
These are analyst thesis pieces with maintained targets; without new earnings, guidance, or hard datapoints, the market may already be pricing the turnaround narratives.
Key entities
- institutionBofA
Provides bullish price targets and turnaround/growth theses for multiple stocks discussed in the article.
- analystCarey Hall
The named BofA analyst whose written rationale is quoted for several of the picks.
